Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Astrazeneca Plc ADR
(NQ:
AZN
)
83.00
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Astrazeneca Plc ADR
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
47
48
Next >
AstraZeneca, GSK's COVID-19 Therapies Lose Efficacy Against Omicron's Subvariants
February 25, 2022
The FDA authorized an increased dose in the case of AstraZeneca Plc's (NASDAQ: AZN) pre-exposure prophylaxis drug Evusheld (tixagevimab and cilgavimab)....
Via
Benzinga
Stock Market Tumbles, Rebounds As Russia Invades Ukraine: Weekly Review
February 25, 2022
The stock market fell back into a correction, but is trying to rally back.
Via
Investor's Business Daily
Red Ink
February 24, 2022
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph
Via
Talk Markets
4 Pharma Stocks to Buy Even if the Pandemic Ends
February 24, 2022
Here are four pharma stocks that looks attractive for the long-term. Deep product development pipelines will ensure steady revenue and cash flow growth.
Via
InvestorPlace
AstraZeneca: Q4 Earnings Insights
February 10, 2022
AstraZeneca (NASDAQ:AZN) reported its Q4 earnings results on Thursday, February 10, 2022 at 02:15 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Blood Clot Risk After First AstraZeneca COVID-19 Shot Very Small - UK Study Shows
February 23, 2022
A large study into rare blood clots linked with AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine found between one and three cases per million, and only after...
Via
Benzinga
7 Safe Stocks to Buy If You Fear the Bear
February 23, 2022
Safe stocks tend to perform well no matter what the broader market does. Here are seven defensive companies to research further.
Via
InvestorPlace
AstraZeneca Gaps Higher After Touting 'Historic' And Unexpected Win In Breast Cancer
February 22, 2022
The company is testing a HER2 drug. It showed unexpected promise in some patients.
Via
Investor's Business Daily
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
February 22, 2022
Roche Holdings AG (OTC: RHHBY) has decided to close out a patent infringement lawsuit against AstraZeneca plc (NASDAQ: AZN), centering around the latter's newly...
Via
Benzinga
AstraZeneca's Enhertu Meets Primary Endpoint In HER2-Low Breast Cancer Setting
February 22, 2022
AstraZeneca plc (NASDAQ: AZN) said that Enhertu prolonged survival and slowed the progression of metastatic breast cancer with low levels of a protein known as HER2...
Via
Benzinga
70 Firms Going Ex-Dividend Next Week, Including GlaxoSmithKline, Dow And AstraZeneca
February 19, 2022
Ex-dividend dates are important to dividend investors because one must own a stock prior to its ex-dividend date in order to be eligible to receive its next dividend.
Via
Talk Markets
GSK Halts Late-Stage RSV Vaccine Trial In Pregnant Women
February 18, 2022
GlaxoSmithKline plc (NYSE: GSK) has paused a late-stage trial of its respiratory syncytial virus (RSV) vaccine candidate in pregnant women based on safety...
Via
Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Agios's Metabolic Disorder Treatment Receives FDA Approval (NASDAQ: AGIO...
Via
Benzinga
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?
February 17, 2022
Can the formerly red-hot biotech segment return to its previous glory?
Via
Investor's Business Daily
Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters
February 16, 2022
According to officials and internal World Health Organization documents reviewed by Reuters, the relatively short shelf life of AstraZeneca Plc's (NASDAQ: AZN)...
Via
Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
February 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Economic Data, Fed Minutes
February 16, 2022
Pre-open movers
Via
Benzinga
Why Are AstraZeneca Shares Trading Higher Today
February 15, 2022
Adding AstraZeneca Plc's (NASDAQ: AZN) Lynparza to Johnson & Johnson's (NYSE: JNJ) Zytiga (abiraterone) extended the time to live without disease...
Via
Benzinga
AstraZeneca Stock Ranked No. 1 In Group; Recently Reported Record Sales, Strong Outlook
February 14, 2022
AstraZeneca reported record sales, and a bullish outlook. AstraZeneca stock is idling though amid market weakness. Setting up for run higher?
Via
Investor's Business Daily
Large Cap Biopharma- Well Positioned For Choppy Markets
February 14, 2022
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets.
Via
Talk Markets
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate...
Via
Talk Markets
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...
Via
Benzinga
Stock Market Rally Stalls As Inflation, Treasury Yields Soar: Weekly Review
February 11, 2022
The stock market rally remains stuck in a recent range as the major indexes slashed weekly gains on hot inflation. Treasury yields surged.
Via
Investor's Business Daily
Two Insider Moonshots Rising on Sudden Buying
February 10, 2022
Biotech insiders are among the most important investors to pay close attention to. Here are two that show good signs for the future.
Via
InvestorPlace
42 Stocks Moving In Thursday's Mid-Day Session
February 10, 2022
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares climbed 63.3% to $3.45 following the company's recent uplisting to the Nasdaq. BRC Inc. (NYSE: BRCC) climbed 35.8...
Via
Benzinga
Seagen Crumbles With AstraZeneca Expected To Pressure Its New Drug
February 10, 2022
Seagen called for lower-than-expected 2022 sales of Tukysa, a breast cancer drug.
Via
Investor's Business Daily
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
AstraZeneca Records Bumper COVID-19 Vaccine Sales Of $4B In FY21
February 10, 2022
Core earnings per share (EPS) came in at $1.67, topping estimates of $0.73.
Via
Talk Markets
21 Stocks Moving in Thursday's Pre-Market Session
February 10, 2022
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Also check out this: Executives Sell More Than $210M Of 5...
Via
Benzinga
AstraZeneca Records Bumper COVID-19 Vaccine Sales Of ~$4B In FY21
February 10, 2022
AstraZeneca Plc's (NASDAQ: AZN) total revenue jumped 63% Y/Y to $12.0
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
47
48
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.